Product Information
LEVOCARNITINE SF 1 G/10 ML SOL is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2522 per ML under NDC 70954014010. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Aug 14, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 g/10mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954014010
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOCARNITINEApproval Type
Generic (ANDA)
FDA Application
ANDA211676FDA Approved
8/14/2019
TE Code
AA
On Market Since
8/14/2019
Pharmacological Classes
Price Statistics
The NADAC for LEVOCARNITINE SF 1 G/10 ML SOL has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2522 per ML |
|---|---|
| All-time high | $0.2595 (Jun 10, 2026) |
| All-time low | $0.2059 (Jul 17, 2024) |
| 52-week high | $0.2595 |
| 52-week low | $0.2221 |
| Median price | $0.2307 |
| Average price | $0.2344 |
| Largest weekly change | +6.1% (Jan 22, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levocarnitine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carnitine Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOCARNITINE SF 1 G/10 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCARNITINE SF 1 G/10 ML SOL, manufactured by ANI Pharmaceuticals, Inc., is $0.2522 per ML (NDC 70954014010), effective Sep 30, 2026.
How has the price of LEVOCARNITINE SF 1 G/10 ML SOL changed over time?
Over the history we have for it, the NADAC for LEVOCARNITINE SF 1 G/10 ML SOL has risen 15.6%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LEVOCARNITINE SF 1 G/10 ML SOL?
Since Apr 17, 2024, the NADAC for LEVOCARNITINE SF 1 G/10 ML SOL has ranged from a low of $0.2059 (Jul 17, 2024) to a high of $0.2595 (Jun 10, 2026), with a median of $0.2307 per ML.
Are there cheaper alternatives to LEVOCARNITINE SF 1 G/10 ML SOL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOCARNITINE 1 G/10 ML SOLN, is $0.1450 per ML — about 42% below LEVOCARNITINE SF 1 G/10 ML SOL.
Who manufactures LEVOCARNITINE SF 1 G/10 ML SOL?
LEVOCARNITINE SF 1 G/10 ML SOL (NDC 70954014010) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.